Daniel Marsh

Daniel Marsh

Senior Markets Analyst

Daniel Marsh is a senior markets analyst at StockTi with over 12 years of experience covering U.S. and global equity markets. He holds a CFA charter and previously worked as an equity research associate at a major Wall Street firm. Daniel specializes in macroeconomic analysis, market trends, and cross-sector investment themes. His work focuses on translating complex market data into actionable insights for individual and institutional investors.

Markets, Economy, Analysis 4,427 articles

Articles by Daniel Marsh

Dow Hits New Record as Wall Street Eyes Inflation Data and Earnings
Markets

Dow Hits New Record as Wall Street Eyes Inflation Data and Earnings

The Dow Jones Industrial Average surged to a new record close of 50,714.31 on Friday, led by gains in semiconductor and PC stocks, as optimism over U.S.-Iran talks and strong earnings buoyed markets.

DELL HPQ QCOM NVDA INTC AMD SPY QQQ TLT USO GLD
Hyliion Surges on Navy Interest in KARNO Generator Technology
Markets

Hyliion Surges on Navy Interest in KARNO Generator Technology

Hyliion shares surged nearly 40% after a U.S. Navy trial update on its KARNO generator platform, with commercialization of the 200-kW module expected late this year.

HYLN BE FCEL
Millrose Properties in Spotlight as Dream Finders Presses Beazer Bid
Markets

Millrose Properties in Spotlight as Dream Finders Presses Beazer Bid

Millrose Properties shares rose to $27.65 after Dream Finders Homes renewed its $25.75/share cash bid for Beazer Homes, with Millrose offering up to $500M in land-banking capital.

DFH BZH LEN
Opendoor Shares Steady as Mortgage Rate Climb Pressures Housing Market
Markets

Opendoor Shares Steady as Mortgage Rate Climb Pressures Housing Market

Opendoor shares traded flat near $4.55 as rising mortgage rates and a drop in housing starts offset recent gains. The company reported improved gross margins but a wider net loss in Q1.

OPEN Z OPAD
Family Dollar Shutters Over 350 Stores, Testing Private-Equity Turnaround
Markets

Family Dollar Shutters Over 350 Stores, Testing Private-Equity Turnaround

Family Dollar closed at least 350 stores in 10 months, hitting Southern and Appalachian areas hard. New private-equity owners face a test of their turnaround strategy.

DLTR DG WMT
Uber Eyes Full Takeover of Delivery Hero, Intensifying Food Delivery Rivalry
Markets

Uber Eyes Full Takeover of Delivery Hero, Intensifying Food Delivery Rivalry

Uber is exploring a full takeover of Delivery Hero after raising its stake to 19.5%, Bloomberg reports. A further increase to 30% would trigger a mandatory offer.

UBER
Ondas Charts Next Move After $196.6M Omnisys Acquisition
Markets

Ondas Charts Next Move After $196.6M Omnisys Acquisition

Ondas shares edged up 0.54% to $9.23 after closing its $196.6M stock acquisition of Omnisys, while a resale filing for 2.7 million Mistral shares adds overhang.

ONDS AVAV
PicoCELA Surges 141% on Nasdaq as Thin Float Fuels Volatility
Markets

PicoCELA Surges 141% on Nasdaq as Thin Float Fuels Volatility

PicoCELA's U.S.-listed shares surged 141% to $5.43 on Friday, extending a two-day rally with no new operating news, as traders piled into the thinly traded stock ahead of a key shareholder vote.

Dow Hits New Intraday Record as Peace Hopes Lift Sentiment
Markets

Dow Hits New Intraday Record as Peace Hopes Lift Sentiment

The Dow Jones Industrial Average reached a new intraday high, buoyed by peace hopes and tech earnings.

DIA SPY QQQ CSCO AMZN NVDA
Dow Jones Hits New Record as U.S.-Iran Talks and AI Rally Boost Markets
Markets

Dow Jones Hits New Record as U.S.-Iran Talks and AI Rally Boost Markets

The Dow Jones Industrial Average hit a record intraday high of 50,712.24 on Friday, closing up 0.66% at 50,616.45, driven by U.S.-Iran peace talks, strong earnings, and AI stock gains.

DIA SPY QQQ CSCO AMZN NVDA
Mister Car Wash Delisted After $3.1B Buyout by Leonard Green
Markets

Mister Car Wash Delisted After $3.1B Buyout by Leonard Green

Mister Car Wash shares are no longer trading after Leonard Green completed a $3.1 billion buyout, paying $7.00 per share to eligible holders.

MCW
Akari Therapeutics Surges on Promising KRAS Cancer Data and $5.5M Financing
Markets

Akari Therapeutics Surges on Promising KRAS Cancer Data and $5.5M Financing

Akari Therapeutics shares surged over 100% in premarket trading after its lead drug candidate AKTX-101 showed positive preclinical results in KRAS-mutated pancreatic cancer models and the company announced a $5.5 million private placement.

AKTS